Life Sciences Market Research Reports

Titlepublishedprice

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 – New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

By GBI Research
"......to the indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises the US, UK, France, Germany, Italy, Spain, Japan and Canada. It also covers disease epidemiology, ......"
29-Oct-2014$4995

Aortic Stent Grafts – Current and Future Players

By GlobalData
"......aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. S......"
29-Oct-2014$3500

Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma

By GBI Research
"......emotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. This diversity is partially due to the presence of 12......"
29-Oct-2014$6995

Egypt Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......r and the announced expansion of the Medicare healthcare programme are positive developments this quarter. The challenges faced by pharmaceutical companies wishing to operate in the market are the continued presence of counterfeit medicines, poor ......"
29-Oct-2014$1295

Indonesia Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......The ongoing implementation of the universal healthcare scheme in Indonesia coupled with the impending launch of the ASEAN Economic Community will provide growth opportunities for pharmaceutical firms. However, we highlight that the universal healt......"
29-Oct-2014$1295

Moldova Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ket grows over the coming years. Headline Expenditure Projections ? Pharmaceuticals: MDL2.73bn (USD214mn) in 2013 to MDL2.9bn (USD226mn) in 2014; +5.7% in local currency terms and +5.4% in US dollar terms. Forecast unchanged from Q314. ? Healthc......"
29-Oct-2014$1295

Sri Lanka Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......hcare sector growth will outpace economic growth over the five-year forecast period. Improved relations with India, after the country abstained from voting on the UNHCR resolution, are likely to spur further investments from Indian hospital groups......"
29-Oct-2014$1295

2014 Deep Research Report on Global and China Nalbuphine HCL Industry

By QYResearch Group
"......domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Nalbuphine HCL industry policy and plan, Nalbuphine HCL product specification, manufacturing process, product cost structure etc. then statistics Globa......"
28-Oct-2014$2200

2014 Deep Research Report on Global and China Naltrexone HCL Industry

By QYResearch Group
"......arket analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Naltrexone HCL production and market share, Naltrexone HCL industry policy and plan, Naltre......"
28-Oct-2014$2200

RNA Interference Screening Trends 2014

By HTStec Ltd
"......marketplaces and to update our previous report in siRNA screening (published September 2012). The questionnaire was compiled to meet the needs, requirements and interests of the RNAi screening vendor community. The main objectives were to comprehen......"
27-Oct-2014$2500
Live Chat
Live Chat by Comm100